Related Experiment Video
Updated: Aug 4, 2026

Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
A case of rifampicin induced pseudomembraneous colitis
Daad H Akbar1, Halia Z Al-Shehri, Amani M Al-Huzali
1Department of Medicine, King Abdul-Aziz University Hospital, Jeddah, Kingdom of Saudi Arabia. daadakb@yahoo.com
Abstract:
We report a case pf pseudomembranous colitis that developed in a patient with tuberculous abdominal lymphadenopathy during treatment with rifampicin. The patient had delayed presentation (3 months) after the start of rifampicin. She had one relapse after 2 months that was successfully treated, and she finished her antituberculosis therapy without any further relapses. Awareness of this serious complication of rifampicin therapy should be encountered.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Clinical Significance of Antibiotic Resistance
Inflammatory Bowel Disease II: Ulcerative Colitis

